Chevy Chase Trust
BSX icon

Chevy Chase Trust’s Boston Scientific BSX Stock Holding History

Chevy Chase Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6M Sell
717,888
-15,243
-2% -$828K 0.08% 210
2026
Q1 		$46M Sell
733,131
-18,976
-3% -$1.52M 0.13% 137
2025
Q4 		$71.7M Sell
752,107
-4,316
-0.6% -$423K 0.19% 105
2025
Q3 		$73.8M Sell
756,423
-25,251
-3% -$2.61M 0.2% 103
2025
Q2 		$84M Buy
781,674
+8,509
+1% +$861K 0.24% 85
2025
Q1 		$78M Sell
773,165
-455
-0.1% -$45.8K 0.25% 83
2024
Q4 		$69.1M Sell
773,620
-16,152
-2% -$1.42M 0.21% 97
2024
Q3 		$66.2M Sell
789,772
-13,076
-2% -$1.03M 0.2% 94
2024
Q2 		$61.8M Sell
802,848
-8,543
-1% -$625K 0.2% 102
2024
Q1 		$55.6M Sell
811,391
-6,573
-0.8% -$423K 0.18% 119
2023
Q4 		$47.3M Sell
817,964
-5,190
-0.6% -$277K 0.17% 122
2023
Q3 		$43.5M Sell
823,154
-3,924
-0.5% -$206K 0.17% 118
2023
Q2 		$44.7M Sell
827,078
-5,269
-0.6% -$275K 0.17% 123
2023
Q1 		$41.6M Buy
832,347
+8,058
+1% +$380K 0.16% 127
2022
Q4 		$38.1M Sell
824,289
-50,172
-6% -$2.17M 0.16% 129
2022
Q3 		$33.9M Buy
874,461
+10,835
+1% +$435K 0.14% 142
2022
Q2 		$32.2M Buy
863,626
+6,485
+0.8% +$264K 0.13% 156
2022
Q1 		$38M Sell
857,141
-457
-0.1% -$19.8K 0.13% 153
2021
Q4 		$36.4M Sell
857,598
-19,972
-2% -$839K 0.12% 163
2021
Q3 		$38.1M Sell
877,570
-31,422
-3% -$1.39M 0.13% 153
2021
Q2 		$38.9M Sell
908,992
-45,471
-5% -$1.91M 0.13% 155
2021
Q1 		$36.9M Sell
954,463
-76,644
-7% -$2.9M 0.13% 160
2020
Q4 		$37.1M Sell
1,031,107
-29,938
-3% -$1.08M 0.13% 160
2020
Q3 		$40.5M Sell
1,061,045
-88,810
-8% -$3.42M 0.16% 139
2020
Q2 		$40.4M Sell
1,149,855
-35,106
-3% -$1.26M 0.16% 140
2020
Q1 		$38.7M Buy
1,184,961
+19,584
+2% +$765K 0.18% 129
2019
Q4 		$52.7M Buy
1,165,377
+1,596
+0.1% +$66.8K 0.2% 118
2019
Q3 		$47.4M Buy
1,163,781
+2,409
+0.2% +$102K 0.19% 120
2019
Q2 		$49.9M Buy
1,161,372
+4,964
+0.4% +$191K 0.21% 112
2019
Q1 		$43M Buy
1,156,408
+17,356
+2% +$663K 0.18% 125
2018
Q4 		$40.3M Buy
1,139,052
+3,385
+0.3% +$123K 0.2% 119
2018
Q3 		$43.7M Sell
1,135,667
-25,470
-2% -$890K 0.18% 129
2018
Q2 		$38M Sell
1,161,137
-1,570
-0.1% -$47.4K 0.16% 144
2018
Q1 		$31.8M Sell
1,162,707
-27,733
-2% -$754K 0.14% 171
2017
Q4 		$29.5M Sell
1,190,440
-7,147
-0.6% -$197K 0.13% 187
2017
Q3 		$34.9M Buy
1,197,587
+16,992
+1% +$469K 0.16% 152
2017
Q2 		$32.7M Buy
1,180,595
+3,908
+0.3% +$104K 0.16% 154
2017
Q1 		$29.3M Buy
1,176,687
+37,547
+3% +$913K 0.14% 167
2016
Q4 		$24.6M Buy
1,139,140
+2,317
+0.2% +$50.6K 0.13% 182
2016
Q3 		$27.1M Sell
1,136,823
-23,705
-2% -$565K 0.15% 167
2016
Q2 		$27.1M Buy
1,160,528
+19,969
+2% +$432K 0.15% 160
2016
Q1 		$21.5M Buy
1,140,559
+28,825
+3% +$506K 0.12% 195
2015
Q4 		$20.5M Buy
1,111,734
+9,659
+0.9% +$173K 0.12% 204
2015
Q3 		$18.1M Buy
1,102,075
+40,995
+4% +$701K 0.11% 214
2015
Q2 		$18.8M Buy
1,061,080
+21,527
+2% +$385K 0.11% 213
2015
Q1 		$18.5M Buy
1,039,553
+39,057
+4% +$617K 0.11% 217
2014
Q4 		$13.3M Sell
1,000,496
-7,921
-0.8% -$101K 0.08% 278
2014
Q3 		$11.9M Buy
1,008,417
+63,988
+7% +$806K 0.08% 286
2014
Q2 		$12.1M Sell
944,429
-20,537
-2% -$267K 0.08% 273
2014
Q1 		$13M Sell
964,966
-7,384
-0.8% -$96.9K 0.09% 247
2013
Q4 		$11.7M Buy
972,350
+7,451
+0.8% +$88K 0.09% 269
2013
Q3 		$11.3M Buy
964,899
+19,283
+2% +$209K 0.09% 258
2013
Q2 		$8.77M Buy
+945,616
New +$8.02M 0.08% 302

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chevy Chase Trust's BSX Position: Q2 2026 in Review

Chevy Chase Trust reduced its Boston Scientific (BSX) stake by 2.1% in Q2 2026, selling an estimated $828K and leaving 717,888 shares worth $30.6M. The position accounts for 0.08% of the portfolio, ranked #210.

Chevy Chase Trust first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $84M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Chevy Chase Trust held 717,888 shares of Boston Scientific worth $30.6M as of Q2 2026.
  • Chevy Chase Trust sold 15,243 Boston Scientific shares in Q2 2026, an estimated $828K.
  • Boston Scientific made up 0.08% of Chevy Chase Trust's portfolio in Q2 2026, its #210 holding.
  • Chevy Chase Trust first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Chevy Chase Trust's Boston Scientific position peaked at $84M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.